WIlliam Robert Wilson
机构: Emeritus Professor, University of Auckland
每年引用次数
引用次数
引用: 22,598
H-指数: 72
I10-指数 : 250
出版物: 439
Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
WilliamR Wilson , AlanE Li , DavidS.M Cowan , BronwynG Siim
International Journal of Radiation Oncology Biology Physics 42 ( 4) 905 -908
93
1998
Cytokinetic resistance of Lewis lung carcinoma to cyclophosphamide and the amsacrine derivative CI-921.
Baguley Bc , Wilson Wr , Finlay Gj
Progress in Clinical and Biological Research 223 47 -61
10
1986
Radiation-activated prodrugs as hypoxia-selective cytotoxins: model studies with nitroarylmethyl quaternary salts.
Denny Wa , Wilson Wr , Anderson Rf , Tercel M
Anti-cancer Drug Design 13 ( 6) 663 -685
40
1998
Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
Wilson Wr , Bleumink Ar , Jensen Cg
Cancer Research 45 ( 2) 717 -725
24
1985
Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents.
Zwi Lj , Baguley Bc , Gavin Jb , Wilson Wr
Oncology Research 6 ( 2) 79 -85
93
1994
Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.
Denny Wa , Palmer Bd , Wilson Wr
Anti-cancer Drug Design 5 ( 4) 337 -349
6
1990
Measurement of extravascular drug diffusion in multicellular layers.
Wilson Wr , Hicks Ko
British Journal of Cancer 79 1623 -1626
23
1999
In vitro and in vivo assessment of activity of new anilino-substituted analogues of amsacrine against Lewis lung carcinoma
Denny Wa , Baguley Bc , Rewcastle Gw , Wilson Wr
Anti-cancer Drug Design 1 ( 3) 215 -222
4
1986
The design of cobalt(III) complexes of phenazine-1-carboxamides as prointercalators and potential hypoxia-selective cytotoxins.
Denny Wa , Wilson Wr , Perrin Lc , McFadyen Wd
Anti-cancer Drug Design 14 ( 3) 231 -241
8
1999
Recent developments in the design of bioreductive drugs.
W. A. Denny , W. R. Wilson , M. P. Hay
The British journal of cancer. Supplement 27
45
1996
Pulse radiolysis studies on the hypoxia-selective toxicity of a colbalt-mustard complex.
W. A. Denny , D. C. Ware , R. F. Anderson , W. R. Wilson
The British journal of cancer. Supplement 27
8
1996
Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1.
W. A. Denny , M. P. Hay , R. M. Batchelder , W. R. Wilson
The British journal of cancer. Supplement 27
15
1996
Multicellular membranes as an in vitro model for extravascular diffusion in tumours.
W. R. Wilson , K. O. Hicks , D. S. Cowan
The British journal of cancer. Supplement 27
74
1996
Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
B. C. Baguley , L.-M. Ching , W. L. Browne , W. R. Wilson
Anticancer Research 18 4409 -4413
24
1998
Quantitative structure-activity relationships for the cytotoxicity of substituted aniline mustards in tissue culture
W. R. Wilson , W. A. Denny , B. D. Palmer
American Chemical Society. National meeting. 196 ( 413) 291 -300
1989
The effects of kinship on the growth of juvenile Arctic charr
G. E. Brown , J. A. Brown , W. R. Wilson
Journal of Fish Biology 48 ( 3) 313 -320
27
1996
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
M. Konopleva , P. F. Thall , C. A. Yi , G. Borthakur
Haematologica 100 ( 7) 927 -934
101
2015
Final results of a phase Ib trial of PR104, a pre-prodrug of the bioreductive prodrug PR104A, in combination with gemcitabine (G) or docetaxel (D) in patients with advanced solid tumors.
M. B. Jameson , M. J. McKeage , R. K. Ramanathan , J. Rajendran
Journal of Clinical Oncology 28 2554 -2554
4
2010
The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
C. P. Guise , M. R. Abbattista , R. S. Singleton , S. D. Holford
Cancer Research 70 ( 4) 1573 -1584
106
2010
Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid
Lindy L. Thomsen , Bruce C. Baguley , W. R. Wilson
Cancer Chemotherapy and Pharmacology 31 ( 2) 151 -155
21
1992